Schedule 13D ownership disclosure
PROTEON THERAPEUTICS INC
Security class unavailable · CUSIP: 74371L109
Event date: 2014-10-27
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 1,432,930
- Percent of class
- 9.6000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-14-076010
- Form type
- SC 13D
- Filer
- Protara Therapeutics, Inc.
- CIK
- CIK 1359931
- Filed
- Nov 03, 2014
- Reporting period
- Oct 27, 2014
- Description
- Schedule 13D beneficial ownership